SVT (Supraventricular Tachycardia)
Critical Alerts
- Unstable = Cardiovert: Hypotension, AMS, chest pain, acute heart failure
- Adenosine is diagnostic AND therapeutic: Terminates most re-entrant SVTs
- Give adenosine rapidly: Push fast with flush, closest port possible
- Wide complex SVT may be VT: If unsure, treat as VT
- Vagal maneuvers first: Safe, can terminate
- WPW with AF is DANGEROUS: Avoid AV nodal blockers
Key Diagnostics
| Test | Finding | Significance |
|---|---|---|
| Rate | 150-250 bpm | Typical for SVT |
| QRS | Narrow (<120 ms) | Supraventricular origin |
| Rhythm | Regular (usually) | Irregular = AF, MAT |
| P waves | Often absent or retrograde | Hidden in QRS or ST |
| Response to adenosine | Terminates or unmasks | Diagnostic |
Emergency Treatments
| Condition | Treatment | Dose |
|---|---|---|
| Stable SVT - First line | Vagal maneuvers | Modified Valsalva |
| Stable SVT - If vagal fails | Adenosine | 6 mg rapid IV push → 12 mg → 12 mg |
| Unstable SVT | Synchronized cardioversion | 50-100 J (biphasic) |
| Rate control (if SVT persists) | Diltiazem or Metoprolol | Diltiazem 15-20 mg IV (or 0.25 mg/kg) |
| WPW with AF (wide irregular) | Procainamide or Cardioversion | DO NOT give AV nodal blockers |
Overview
Supraventricular tachycardia (SVT) is a broad term encompassing any tachyarrhythmia arising from above the ventricles. In clinical practice, "SVT" often specifically refers to paroxysmal supraventricular tachycardia (PSVT), a narrow complex, regular tachycardia typically due to re-entrant mechanisms. Most are benign but can cause significant symptoms and rarely hemodynamic compromise.
Classification
Types of SVT:
| Type | Mechanism | Frequency |
|---|---|---|
| AVNRT | Re-entry within AV node | 60-70% |
| AVRT (accessory pathway) | Re-entry using bypass tract | 20-30% |
| Atrial tachycardia | Enhanced automaticity or micro-reentry in atrium | 5-10% |
Other Supraventricular Tachycardias (Broader Definition):
| Arrhythmia | Features |
|---|---|
| Atrial fibrillation | Irregularly irregular |
| Atrial flutter | Regular, flutter waves |
| Multifocal atrial tachycardia | Irregular, ≥3 P wave morphologies |
| Sinus tachycardia | Appropriate for clinical context |
AVNRT (AV Nodal Reentrant Tachycardia)
- Most common PSVT
- Two pathways within AV node (slow and fast)
- Typical AVNRT: Antegrade slow, retrograde fast
- P waves buried in or just after QRS
- "Pseudo R′" in V1 or "pseudo S" in inferior leads
AVRT (AV Reentrant Tachycardia)
- Uses accessory pathway (bypass tract)
- Orthodromic (most common): Antegrade AV node, retrograde accessory pathway → Narrow QRS
- Antidromic (rare): Antegrade accessory pathway, retrograde AV node → Wide QRS
- WPW syndrome: Pre-excitation (delta wave) at baseline
Epidemiology
- Prevalence of PSVT: 2.3 per 1000 adults
- Incidence: 35 episodes per 100,000 person-years
- Age: AVNRT more common in adults; AVRT more common in younger patients
- Gender: AVNRT more common in women (2:1)
- WPW prevalence: 1-3 per 1000
Etiology
Precipitants:
| Factor | Mechanism |
|---|---|
| Caffeine, alcohol | Sympathetic stimulation |
| Stress, anxiety | Catecholamines |
| Medications | Decongestants, stimulants |
| Sleep deprivation | Autonomic tone |
| Electrolyte abnormalities | Cardiac irritability |
| Hyperthyroidism | Increased adrenergic activity |
| Structural heart disease | (Less common in SVT) |
Re-Entry Mechanism
Requirements for Re-Entry:
- Two pathways with different conduction velocities and refractory periods
- Unidirectional block in one pathway
- Slow conduction in the other pathway
- Completed circuit allowing continuous loop
AVNRT:
- Slow and fast pathways within AV node
- PAC blocks in fast pathway → conducts down slow pathway → retrograde up fast pathway
- Continuous circuit
AVRT:
- Circuit includes atria, AV node, ventricles, and accessory pathway
- Orthodromic: Down AV node, up accessory pathway
- Antidromic: Down accessory pathway, up AV node
Hemodynamic Effects
- Loss of AV synchrony (atrial contraction after ventricular)
- Reduced diastolic filling time (fast rate)
- Usually tolerated in structurally normal hearts
- May cause hypotension in patients with heart disease
WPW Danger with Atrial Fibrillation
- Rapid conduction directly to ventricles via accessory pathway
- Can conduct 1:1 at very fast rates (>250 bpm)
- AV nodal blockers paradoxically increase conduction through accessory pathway
- Can degenerate to VF
Symptoms
Typical:
Polyuria: Common during/after episode (atrial natriuretic peptide release)
"Flip" sensation: Moment of initiation or termination
Syncope: Rare; more common with very fast rates or underlying heart disease
History
Key Questions:
Physical Examination
Vital Signs:
| Finding | Typical Value |
|---|---|
| Heart rate | 150-250 bpm |
| Blood pressure | Usually maintained; may be low |
| Respiratory rate | Often elevated |
| SpO2 | Usually normal |
Cardiovascular:
Signs of Instability:
Unstable SVT (Cardiovert Immediately)
| Finding | Concern | Action |
|---|---|---|
| Hypotension (SBP <90) | Hemodynamic compromise | Synchronized cardioversion |
| Altered mental status | Hypoperfusion | Synchronized cardioversion |
| Severe chest pain | Ischemia | Synchronized cardioversion |
| Acute pulmonary edema | Heart failure | Synchronized cardioversion |
| Signs of shock | End-organ dysfunction | Synchronized cardioversion |
Wide Complex SVT
| Concern | Action |
|---|---|
| May be VT | If unsure, treat as VT |
| WPW with antidromic conduction | Adenosine may be used cautiously |
| SVT with aberrancy | Adenosine diagnostic |
| WPW with AF (irregularly irregular wide) | AVOID AV nodal blockers |
Narrow Complex Tachycardia
| Diagnosis | Features |
|---|---|
| SVT (PSVT) | Regular, rate 150-250, sudden onset/offset |
| Sinus tachycardia | Gradual onset, P waves before QRS, appropriate for clinical state |
| Atrial flutter | Regular (often ~150 bpm with 2:1 block), sawtooth flutter waves |
| Atrial fibrillation | Irregularly irregular |
| MAT | Irregular, ≥3 different P wave morphologies |
Wide Complex Tachycardia
| Diagnosis | Features |
|---|---|
| VT | Wide, often regular, AV dissociation |
| SVT with aberrancy (LBBB, RBBB) | Bundle branch block at fast rate |
| SVT with preexisting BBB | Known prior BBB |
| Antidromic AVRT | WPW with antegrade accessory pathway |
| WPW with AF | Irregularly irregular, wide, variable morphology |
When in Doubt: Treat wide complex tachycardia as VT
ECG Interpretation
Systematic Approach:
- Rate (usually 150-250 bpm)
- Regularity (regular in PSVT; irregular = AF, flutter with variable block, MAT)
- QRS width (narrow <120 ms = supraventricular)
- P waves (look for hidden P waves in ST or T waves)
- Compare to prior ECG (baseline BBB? Pre-excitation?)
Finding Hidden P Waves:
| Location | Suggests |
|---|---|
| In QRS (pseudo R′ in V1) | AVNRT |
| Just after QRS (short RP) | AVNRT or AVRT |
| Between QRS complexes (long RP) | Atrial tachycardia |
| Sawtooth in inferior leads | Atrial flutter |
Laboratory Studies
| Test | Purpose |
|---|---|
| Electrolytes (K, Mg) | Arrhythmia triggers |
| TSH | Hyperthyroidism |
| Troponin | If chest pain or prolonged episode |
| BNP | If heart failure concern |
| Drug screen | If concern for stimulants |
Response to Adenosine
| Response | Interpretation |
|---|---|
| Terminates | AVNRT or AVRT (most likely) |
| Transiently slows then resumes | Atrial tachycardia, atrial flutter (reveals underlying rhythm) |
| No effect | Likely VT if wide; may need higher dose |
Principles of Management
- Assess stability: Unstable → Cardiovert
- Stable SVT: Vagal maneuvers → Adenosine → Other agents
- Identify the rhythm: ECG during episode
- Treat underlying causes: Electrolytes, hyperthyroidism
- Prevent recurrence: Ablation, long-term medications
Unstable SVT: Synchronized Cardioversion
Indications:
- Hypotension, altered mental status, severe chest pain, acute heart failure
Technique:
| Step | Details |
|---|---|
| Sedation | Brief (etomidate, propofol, midazolam) if time allows |
| Sync mode | Ensure "sync" is activated |
| Energy | 50-100 J biphasic (start low for SVT) |
| Shock | Deliver on R wave |
| Re-assess | Repeat if needed, increase energy |
Stable SVT: Vagal Maneuvers
Modified Valsalva (REVERT Trial):
- Patient semi-recumbent at 45°
- Blow into 10 mL syringe for 15 seconds (create resistance)
- Immediately lie flat and raise legs to 45° for 15 seconds
- Return to sitting
Success Rate: Up to 40-50% with modified technique
Other Vagal Maneuvers:
- Carotid sinus massage (if no carotid bruit, elderly caution)
- Cold water to face (diving reflex)
- Bearing down
Stable SVT: Adenosine
| Dose | Administration |
|---|---|
| 6 mg | Rapid IV push closest to heart (antecubital), immediate 20 mL NS flush |
| 12 mg | If no response after 1-2 minute, repeat |
| 12 mg | May repeat once more |
Special Considerations:
| Situation | Adjustment |
|---|---|
| Central line | Start with 3 mg |
| Theophylline/Caffeine | May need higher dose |
| Dipyridamole or Carbamazepine | Use lower dose |
| Transplant heart | Start with 1 mg |
Warn Patient: Brief chest discomfort, dyspnea, flushing (lasts seconds)
Contraindications:
- Asthma (relative)
- Second or third degree heart block (without pacemaker)
- Sick sinus syndrome (without pacemaker)
Stable SVT: If Adenosine Fails
Calcium Channel Blockers:
| Drug | Dose |
|---|---|
| Diltiazem | 0.25 mg/kg IV (typically 15-20 mg) over 2 min; may repeat 0.35 mg/kg |
| Verapamil | 2.5-5 mg IV over 2 min; may repeat up to 20 mg total |
Beta-Blockers:
| Drug | Dose |
|---|---|
| Metoprolol | 5 mg IV q5min up to 15 mg |
| Esmolol | 500 mcg/kg bolus, then 50-200 mcg/kg/min infusion |
Avoid in:
- Hypotension
- Severe heart failure
- WPW with AF
WPW with Atrial Fibrillation
DO NOT GIVE:
- Adenosine
- Beta-blockers
- Calcium channel blockers
- Digoxin
- Amiodarone (controversial; some avoid)
Treatment Options:
| Option | Details |
|---|---|
| Synchronized cardioversion | If unstable |
| Procainamide | 20-50 mg/min IV (up to 17 mg/kg), then 1-4 mg/min |
| Ibutilide | 1 mg IV over 10 min (can repeat) |
Rate Control (If SVT Persists)
Diltiazem Infusion: 5-15 mg/hr after bolus
Preventing Recurrence
Lifestyle:
- Avoid triggers (caffeine, alcohol, decongestants)
- Adequate sleep
Long-Term Medications:
| Drug Class | Example |
|---|---|
| Beta-blocker | Metoprolol |
| Calcium channel blocker | Diltiazem, Verapamil |
| Antiarrhythmics (rarely) | Flecainide, Propafenone (pill-in-pocket) |
Catheter Ablation:
- Definitive treatment for recurrent SVT
- High success rate (95%+ for AVNRT, 90%+ for AVRT)
- Low complication rate
- Recommended for frequent/symptomatic episodes
Discharge Criteria
- Converted to sinus rhythm
- Hemodynamically stable
- First episode with clear precipitant
- No concerning symptoms at presentation
- Able to follow up
Admission Criteria
- Prolonged episode requiring multiple interventions
- Underlying cardiac disease
- Cardiac ischemia
- Heart failure
- Unable to convert or maintain sinus rhythm
- Requires initiation of antiarrhythmic
Cardiology Follow-Up
- All new SVT episodes
- Consider Holter/event monitor if diagnosis uncertain
- Ablation referral for recurrent episodes
Condition Explanation
- "Your heart went into a fast rhythm called SVT."
- "It's caused by an electrical 'short circuit' in the heart."
- "It's usually not dangerous, but it makes you feel awful."
- "We were able to fix it with [describe treatment]."
Vagal Maneuvers at Home
- Teach modified Valsalva
- "Try these at home if it happens again."
- "If you feel faint, have chest pain, or can't stop it, call 911."
Warning Signs
- Prolonged episode (>15-20 minutes)
- Chest pain
- Syncope or near-syncope
- Severe shortness of breath
Lifestyle Modifications
- Reduce caffeine
- Limit alcohol
- Manage stress
- Adequate sleep
- Avoid decongestants
WPW Syndrome
- Pre-excitation on baseline ECG (short PR, delta wave)
- Risk of sudden death if AF develops (rapid ventricular rate)
- Ablation recommended for symptomatic WPW
- Avoid AV nodal blockers if AF develops
Pregnancy
- SVT relatively common
- Vagal maneuvers first
- Adenosine is safe
- Beta-blockers relatively safe (prefer metoprolol, labetalol)
- Avoid electrical cardioversion unless unstable (safe if needed)
Pediatric
- AVRT more common than AVNRT in children
- WPW more commonly symptomatic
- Adenosine dosing: 0.1 mg/kg (max 6 mg), then 0.2 mg/kg (max 12 mg)
- Vagal maneuvers: Ice to face (diving reflex)
Elderly
- More likely to have underlying heart disease
- More sensitive to hypotension
- Use lower doses of medications
- Carotid massage with caution (check for bruits)
Performance Indicators
| Metric | Target | Rationale |
|---|---|---|
| ECG obtained during tachycardia | 100% | Diagnostic |
| Vagal maneuvers attempted | >0% | Non-invasive, effective |
| Adenosine given if vagal fails | >0% | First-line pharmacotherapy |
| Cardioversion for unstable | 100% | Life-saving |
| Cardiology follow-up arranged | 100% | Ongoing management |
Documentation Requirements
- ECG during tachyarrhythmia
- Rate, rhythm, QRS width
- Stability assessment
- Interventions and response
- Rhythm at discharge
- Follow-up plan
Diagnostic Pearls
- Regular narrow complex at 150 bpm: May be flutter with 2:1 block—look for flutter waves
- Pseudo R′ in V1: Think AVNRT
- Compare to prior ECG: Baseline BBB or pre-excitation?
- Adenosine is diagnostic: Watch the response on the monitor
- Wide complex + irregular: WPW with AF until proven otherwise
- Short RP interval: Likely AVNRT or orthodromic AVRT
Treatment Pearls
- Modified Valsalva works better: Leg elevation component is key
- Push adenosine FAST: With immediate saline flush
- Warn the patient: "You'll feel strange for a few seconds"
- Have defibrillator ready: Rarely degenerates
- If adenosine fails twice, move on: Rate control or cardioversion
- NEVER AV nodal blockers in WPW + AF: Can cause VF
Disposition Pearls
- Most SVT can go home: If converted, stable, first or rare episode
- Teach vagal maneuvers: Patient empowerment
- Refer all for cardiology follow-up: Consider ablation
- WPW needs urgent outpatient EP referral: Definitive treatment is ablation
- Page RL, et al. 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia. Circulation. 2016;133(14):e506-e574.
- Appelboam A, et al. Postural modification to the standard Valsalva manoeuvre for emergency treatment of supraventricular tachycardias (REVERT): a randomised controlled trial. Lancet. 2015;386(10005):1747-1753.
- Brugada J, et al. 2019 ESC Guidelines for the management of patients with supraventricular tachycardia. Eur Heart J. 2020;41(5):655-720.
- Chhabra L, et al. Wolff-Parkinson-White syndrome. Am Fam Physician. 2010;82(8):963-968.
- Link MS. Evaluation and Initial Treatment of Supraventricular Tachycardia. N Engl J Med. 2012;367(15):1438-1448.
- January CT, et al. 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation. Circulation. 2014;130(23):e199-e267.
- UpToDate. Narrow QRS complex tachycardias: Clinical manifestations, diagnosis, and evaluation. 2024.
- UpToDate. Overview of the acute management of tachyarrhythmias. 2024.